Clinical Study

Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments

Table 6

Incidence of cutaneous leishmaniasis in IDR− and IDR+ nonvaccinated and vaccinated volunteers.

Cases of localized cutaneous leishmaniasis and treatment; patients, (%)
Nonvaccinated controlsVaccinated volunteers
IDR−IDR+Post-VTcPost-VT

(59.42) (27.7) (14.75) (30)
S.Ra (26.8) (80) (44.4) (66.7)
Glub (73.2) (20) (55.6) (33.3)

SR: spontaneous remission. Glu: meglumine antimoniate or Glucantime. VT: Leishmania amastigotes (La, Lv, Lb, and Lch) after TLCK treatment and NP-40 extraction.